Paul F. Lizzul, Chief Medical Officer at ANAPTYSBIO, INC (ANAB), sold 4,440 shares at $38.93 ($173K) on 2024-09-16, disclosed to the SEC on 2024-09-17.
Scheduled sale ($173k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.93 | 2,220 | $86K | 50.0% |
| 2 | $38.93 | 2,220 | $86K | 50.0% |
| Total | $38.93 avg | 4,440 | $173K | 100% |
| Filing → |
| ANAB | SELL | 2026-01-06 | $183K | — | Filing → |
| ANAB | SELL | 2025-12-23 | $75K | — | Filing → |
| ANAB | SELL | 2024-09-24 | $58K | — | Filing → |